RevBio, Inc.

Congratulations to RevBio Chief Medical Officer and Clinical Advisor, Dr. Kevin Foley, M.D. who has been honored as a Health Care Hero and featured in Memphis Business Journal! #HealthCareHero #Proud #RevBio #TETRANITE #novelproduct #medicaldevices #boneadhesive #innovation #medicalcare #biomedical

We’re just four weeks away from LSI Europe ’24, the premier partnering event in the Medtech industry. Next month, CEO Brian Hess, will be traveling to Sintra, Portugal, to showcase RevBio, Inc. and our groundbreaking bone adhesive, TETRANITE, to a targeted audience of investors, strategic partners, and industry leaders. LSI Europe is not your typical conference or trade show; it’s a unique partnering event crafted to foster meaningful connections and drive growth for early-stage companies in the Medtech space. We’re excited to attend LSI for the fourth time, as it consistently delivers exceptional experiences. If you will be attending LSI Europe ’24, don’t miss Brian’s presentation on Wednesday, September 18th at 11:10 AM (Track 3). Be sure to add it to your calendar! You can also search for Brian Hess on the partnering app to set up a one-on-one meeting at LSI. We look forward to seeing you in Portugal! #LSIEurope24 #LSIAlumni #Medtech #Healthech #MedicalDevices #TETRANITE #BoneAdhesive #NovelProducts #Healthcare #RegenerativeMedicine #BoneRegeneration #Biomimicry #Biomimetics #LifeSciences #PartneringEvent #Investment

RevBio is proud to sponsor the McGill University Rocket Team’s Payload Project. The McGill Rocket Team consists of a group of 250 students who team up to design, manufacture, and launch sounding rockets each year at rocketry competitions in order to fulfill their mission of fostering the next generation of industry leaders. The Payload subteam is responsible for designing a scientific experiment to go inside the rocket.   The McGill Rocket Team is integrating our novel bone adhesive, TETRANITE, into their experimental design to investigate the potential for our adhesive to remove barriers to enter space for astronauts with surgical implants. “We hope that this would allow astronauts who need fracture repair surgery before/during space flight to continue their missions safely despite having orthopedic implants in their body”, states Caroline Woodard, MRT Payload Orthopedics Project Lead and former RevBio Co-Op.   The team is currently attending the Launch Canada conference and rocket launch event in Timmins Ontario, launching Project Thorondor which contains the TETRANITE experiment. Stay tuned for updates on the upcoming launch! #McGillRocketTeam #LaunchCanada #launchcanada2024 #RevBio #TETRANITE #rockets #rocketlaunch #soundingrocket #rocketry #scientific #spacetravel #boneadhesive #regenerativemedicine #osteoporosis #biomimetic #mcgilluniversity

The INTINILAB at the University of Pittsburgh School of Dental Medicine presented the results of its investigation on bone loss and spaceflight at the 2024 ISSRDC in Boston. Stay tuned to find out how the INTINILAB, in collaboration with REVBIO Inc., is helping the ISS National Laboratory and NASA to keep astronauts healthy on future long-term missions to the Moon and Mars.

This week, Brian Hess, CEO of RevBio, Inc., joined Dr. Giuseppe Intini and Dr. Roberta Di Carlo at the International Space Station National Laboratory Research & Development Conference in Boston. Dr. Intini delivered a compelling presentation on the topic of bone regeneration in space vs. here on earth. The research Dr. Intini presented provided the groundwork for how RevBio’s innovative bone adhesive, TETRANITE®, can aid in bone regeneration and counteract the bone loss that astronauts experience during space missions. Astronauts routinely are subjected to substantial “premature osteoporosis” due to the microgravity conditions they encounter in space. Bone density in their hips and spine has been recorded to decline by up to 2% per month. As a result, the International Space Station provides a unique lab to test treatments targeted at patients with osteoporosis. Dr. Intini’s presentation also highlighted initial findings from RevBio’s most recent experiment conducted on the International Space Station in collaboration with the Intini Lab at the University of Pittsburgh. This research will assess the rate and quality of new bone formation in mice treated with TETRANITE that subsequently were exposed to microgravity for a significant period of time while onboard the International Space Station. Stay tuned for more updates on the results from TETRANITE’s space mission in the coming months. #TETRANITE #BoneAdhesive #SpaceTravel #biomedical #engineering #osteoporosis #researchanddevelopment #regenerativemedicine #bonedensity #ISSRDC2024 #RevBio

Meet Dave Kosh, RevBio's Advanced Manufacturing Manager. Dave is a true cornerstone of the company, having co-founded RevBio and dedicated nearly a decade to its growth and success. Dave oversees many critical responsibilities at RevBio: from meticulous documentation to ensuring impeccable product manufacturing and maintaining rigorous quality systems. His dynamic role keeps him constantly challenged—an environment he thrives in.   But Dave isn't just about precision and process. In the office, he's also known for igniting laughter and productivity. "Dave not only fires up the lab furnaces for product calcination, but he also fires up the team with his humor and infectious personality," shares a colleague. Outside the lab, Dave's personal interests include camping with his friends and family and cooking up some legendary barbeque!    Dave's journey at RevBio is a testament to his unwavering dedication and the profound impact he has had on both his colleagues and the company's success. Swipe to learn more about Dave's remarkable contributions to RevBio—where his passion continues to fuel innovation and camaraderie every day. We're incredibly grateful to have David Kosh as an integral part of our team! #EmployeeHighlight #EmployeeAppreciation #Proud #RevBio #Manufacturing #ProductManufacturing #TETRANITE #MedicalDevices #BoneRepair #RegenerativeMedicine #clinicalstagecompany #medtech #lifesciences

The RevBio team extends our congratulations to our Chief Medical Officer and Advisory Board Member, Kevin Foley, M.D. for this prestigious achievement. Dr. Foley is a finalist in the "Health Care Innovations" category at the upcoming Memphis Business Journal 2024 Health Care Heroes Awards. We wish him success at the upcoming ceremony. Way to go, Dr. Foley! #HealthCareHero #ClinicalAdvisor #Medicine #Neuro #Spine #RevBio #TETRANITE #NovelProduct #BoneAdhesive #RegenerativeMedicine #BoneRegeneration

Thank you LSI for sharing this clip from CEO Brian Hess’ Studio Interview from LSI USA ’24! Check out the video below to learn more about RevBio’s origin story and the inspiration behind our novel regenerative bone adhesive, TETRANITE. RevBio is grateful for this recognition from LSI. Their events go above and beyond to bring the industry’s leading investors, strategics, and innovators together and we are already looking forward to attending LSI Europe ’24 in Portugal this September! #LSI #lifesciences #TETRANITE #RevBio #BoneAdhesive #Biomimetic #Biomimicry #regenerativemedicine #stability #biodegradability #dental #cranial #orthopedics #orthopaedics #BoneRepair #novelproducts #medicaldevices #FDA  

RevBio is seeking to hire an Analytical Chemist (R&D and QC). Please visit the job posting below to learn more about the role and to apply. #Hiring #Careers #Chemist #researchanddevelopment #MedicalDevices #OpenPositions #BioTech #RevBio #TETRANITE

The industry recognition for our novel bone adhesive keeps coming in! RevBio was featured in the most recent issue of Orthopedic Design & Technology Magazine for their article on orthobiologicss and how novel regenerative cell therapies like TETRANITE® are radically impacting patient healing.    “TETRANITE isn’t just a glue. It’s a regenerative material that can immediately bond bone fragments to boost metal hardware strength and fill gaps in bones. It acts as a scaffold to encourage new bone growth and integrates into the body’s natural healing process. It’s injectable, self-sets, is biocompatible, has bone regenerative capabilities, and touts strength comparable to natural bone”, says RevBio CEO Brian Hess.   Learn more about how RevBio is transforming bone repair for both patients and clinicians by reading the full article, here:  https://lnkd.in/dBd9bTnJ #RevBio #TETRANITE #BoneAdhesive #Fixation #RegenerativeMedicine #BoneRegeneration #Biomimetic #Biomimicry #LifeSciences #Biotech #Biomedical #dental #orthopaedics #orthopedics #BoneGrowth #BoneRepair #biocompatible #patients #clinicians